tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market
VTGN
VistaGen Therapeutics
RESEARCH TOOLSreports
Want to see VTGN full AI Analyst Report?

VistaGen Therapeutics (VTGN) Financial Statements

1,154 Followers

VistaGen Therapeutics Financial Overview

VistaGen Therapeutics's market cap is currently $27.50M. The company's EPS TTM is $-1.87; its P/E ratio is -0.37; VistaGen Therapeutics is scheduled to report earnings on June 15, 2026, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue$ 1.27M$ 486.00K$ 1.06M$ -227.00K$ 1.11M
Gross Profit$ 1.27M$ 486.00K$ 1.06M$ -227.00K$ 1.11M
Operating Income$ -72.13M$ -55.97M$ -33.02M$ -59.27M$ -47.78M
EBITDA$ -71.39M$ -50.78M$ -28.79M$ -58.74M$ -47.05M
Net Income$ -69.69M$ -51.42M$ -29.36M$ -59.25M$ -47.76M
Balance Sheet
Cash & Short-Term Investments$ 45.40M$ 80.48M$ 119.17M$ 16.64M$ 68.14M
Total Assets$ 48.56M$ 84.34M$ 123.65M$ 21.09M$ 74.64M
Total Debt$ 1.04M$ 1.51M$ 2.12M$ 2.71M$ 3.04M
Net Debt$ -29.75M$ -65.62M$ -117.05M$ -13.93M$ -65.10M
Total Liabilities$ 13.04M$ 13.95M$ 9.37M$ 9.01M$ 9.93M
Stockholders' Equity$ 35.52M$ 70.39M$ 114.29M$ 12.08M$ 64.72M
Cash Flow
Free Cash Flow$ -66.44M$ -42.29M$ -25.87M$ -49.93M$ -45.46M
Operating Cash Flow$ -66.44M$ -42.10M$ -25.81M$ -49.72M$ -45.26M
Investing Cash Flow$ -877.00K$ -13.15M$ -61.00K$ -740.00K$ -200.40K
Financing Cash Flow$ 30.97M$ 3.21M$ 128.40M$ -1.04M$ 10.48M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

Income Statement >

VistaGen Therapeutics Debt to Assets

Balance Sheet >

VistaGen Therapeutics Cash Flow

Cash Flow >

VistaGen Therapeutics Forecast EPS vs Actual EPS

Earnings >